Atıf İçin Kopyala
MİRİLİ C., Payday S., GÜNEY İ. B., OĞUL A., GÖKÇAY S., BÜYÜKŞİMŞEK M., ...Daha Fazla
CANCER MANAGEMENT AND RESEARCH, cilt.11, ss.3445-3453, 2019 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
11
-
Basım Tarihi:
2019
-
Doi Numarası:
10.2147/cmar.s191199
-
Dergi Adı:
CANCER MANAGEMENT AND RESEARCH
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.3445-3453
-
Anahtar Kelimeler:
soft tissue sarcoma, STS, pazopanib, angiogenesis, inflammation, neutrophil-to-lymphocyte ratio, NLR, derived neutrophil-to-lymphocyte ratio, DNLR, PROGNOSTIC-FACTORS, LYMPHOCYTE RATIO, CANCER, ANGIOGENESIS, BIOMARKERS, NEUTROPHIL, SURVIVAL, MONOCYTE
-
Çukurova Üniversitesi Adresli:
Evet
Özet
Purpose: The aim of this study was to evaluate the prognostic and predictive value o f neutrophilto-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (DNLR), lymphocyte-tomonocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in soft tissue sarcoma (STS) cases treated with pazopanib.